Question
Statement : According to the latest issue of the
medical journal Lancet, Multidrug Resistant-Tuberculosis (MDR-TB), a version of the disease where patients do not respond to first-line drugs, will become more common than it is now. Course of Action: I. The National TB Programme should consider expanding beyond earlier public private engagement programmes to create new and sustainable partnerships that can help effectively monitor the activities, diagnosis and treatment in the private sector. II. Government should create awareness programs to educate people about how the transmission, diagnosis and treatment of Multidrug Resistant-Tuberculosis (MDR-TB) In each question below a statement is given followed by two courses of action numbered I and II. A course of action is a practicable and feasible step or administrative decision to be taken for follow – up, improvement, or further action in regard to the problem, policy, etc. On the basis of the information given in the statement, you have to assume everything in the statement to be true, and decide which of the suggested courses of action logically follows(s) pursuing.Solution
The correct answer is E
Who is the author of the book "Breaking the Mould: Reimagining India's Economic Future"?Â
“The Quest for a World without Hunger” was written by?
The Book ‘My Passage from India’ is being authored by?
Who released the book 'Dr. APJ Abdul Kalam: Memories Never Die' and what is its significance?
The 2021 Nobel Peace Prize was awarded to Maria Ressa and Dmitry Muratov for their efforts to safeguard freedom of expression which is a precondition fo...
Who Authored the Book 'Gokhale: My Political Guru'?
The book 'Ignited Minds' was written by which of the following authors
Who authored 'Harshacharita', a biography of the Indian emperor Harshavardhana?
The government, SIDBI, and which global organizations are set to launch a $1 billion fund to provide guarantees against loan default to lenders financin...
LIC, ____________________ and New India Assurance are identified as Domestic Systemically Important Insurers (D-SIIs) for 2021-22.